Home › Funds › SR ONE CAPITAL MANAGEMENT, LP › ORIC
SR ONE CAPITAL MANAGEMENT, LP position in ORIC
ORIC PHARMACEUTICALS INC · Health Care
SR ONE CAPITAL MANAGEMENT, LP reported holding 4,615,384 shares of ORIC (ORIC PHARMACEUTICALS INC) in its Q2 2026 13F filing — a position valued at US$50.0M, representing 4.81% of its reported portfolio and ranking #8 among its reported holdings. SR ONE CAPITAL MANAGEMENT, LP has disclosed ORIC holdings in 5 of the last 5 reported quarters, going back to Q2 2025.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How SR ONE CAPITAL MANAGEMENT, LP's ORIC position evolved
SR ONE CAPITAL MANAGEMENT, LP first disclosed a stake in ORIC in Q2 2025 at 4,514,929 shares (US$45.8M). The position peaked in Q1 2026 at 4,514,929 shares, worth US$58.5M. Across 5 filings, SR ONE CAPITAL MANAGEMENT, LP increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 3 time(s). The most recent filing (Q2 2026) shows 4,615,384 shares valued at US$50.0M — an increase of 100,455 shares quarter over quarter..
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2025 | 4.51M | $45.83M | New |
| Q3 2025 | 4.51M | $54.18M | Hold |
| Q4 2025 | 4.51M | $37.75M | Hold |
| Q1 2026 | 4.51M | $58.48M | Hold |
| Q2 2026 | 4.62M | $49.98M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ORIC and 13F data
ORIC (ORIC PHARMACEUTICALS INC) is a Health Care company. 40 other funds we track also report a position in ORIC — the largest reported positions include Nextech Invest Ltd. (US$77.6M), EcoR1 Capital, LLC (US$72.9M), Venrock Adviser, LLC (US$46.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ORIC
- Nextech Invest Ltd. 7.16M sh · $77.57M · Q2 2026
- EcoR1 Capital, LLC 6.73M sh · $72.87M · Q2 2026
- Venrock Adviser, LLC 4.32M sh · $46.78M · Q2 2026
- NEA Management Company, LLC 4.12M sh · $44.60M · Q2 2026
- AIHC Capital Management Ltd 3.83M sh · $41.46M · Q2 2026
- Column Group LLC 3.54M sh · $38.35M · Q2 2026
- Siren, L.L.C. 3.00M sh · $32.47M · Q2 2026
- First Turn Management, LLC 2.02M sh · $21.85M · Q2 2026
- Integral Health Asset Management, LLC 1.90M sh · $20.58M · Q2 2026
- MPM BioImpact LLC 1.88M sh · $20.38M · Q2 2026
- Vivo Capital, LLC 1.85M sh · $20.02M · Q2 2026
- Defilade Capital Management, L.P. 1.05M sh · $11.35M · Q2 2026
More on SR ONE CAPITAL MANAGEMENT, LP
FAQ
How long has SR ONE CAPITAL MANAGEMENT, LP held ORIC?
SR ONE CAPITAL MANAGEMENT, LP has disclosed ORIC holdings in 5 of the last 5 reported quarters, going back to Q2 2025.
What is SR ONE CAPITAL MANAGEMENT, LP's current position in ORIC?
As of Q2 2026, SR ONE CAPITAL MANAGEMENT, LP holds 4.62M shares of ORIC (ORIC PHARMACEUTICALS INC), valued at $49.98M, representing 4.81% of its reported portfolio and ranking #8.
Has SR ONE CAPITAL MANAGEMENT, LP been buying or selling ORIC?
In the latest 13F filing (Q2 2026), SR ONE CAPITAL MANAGEMENT, LP increased its position in ORIC. The position peaked in Q1 2026 at 4.51M shares.
Which other funds hold ORIC?
Other major institutional holders of ORIC include Nextech Invest Ltd., EcoR1 Capital, LLC, Venrock Adviser, LLC, among 40 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.